TR200102501T2 - Antiviral nükleozid analoglar. - Google Patents

Antiviral nükleozid analoglar.

Info

Publication number
TR200102501T2
TR200102501T2 TR2001/02501T TR200102501T TR200102501T2 TR 200102501 T2 TR200102501 T2 TR 200102501T2 TR 2001/02501 T TR2001/02501 T TR 2001/02501T TR 200102501 T TR200102501 T TR 200102501T TR 200102501 T2 TR200102501 T2 TR 200102501T2
Authority
TR
Turkey
Prior art keywords
nucleoside analogs
antiviral nucleoside
antiviral
analogs
formula
Prior art date
Application number
TR2001/02501T
Other languages
English (en)
Turkish (tr)
Inventor
Nguyen-Ba Nghe
Original Assignee
Shire Biochem Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc. filed Critical Shire Biochem Inc.
Publication of TR200102501T2 publication Critical patent/TR200102501T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2001/02501T 1998-12-23 1999-12-22 Antiviral nükleozid analoglar. TR200102501T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11379798P 1998-12-23 1998-12-23

Publications (1)

Publication Number Publication Date
TR200102501T2 true TR200102501T2 (tr) 2002-01-21

Family

ID=22351590

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02501T TR200102501T2 (tr) 1998-12-23 1999-12-22 Antiviral nükleozid analoglar.

Country Status (27)

Country Link
US (3) US6358963B1 (ko)
EP (1) EP1140937B1 (ko)
JP (1) JP2002533470A (ko)
KR (1) KR100653485B1 (ko)
CN (1) CN1117751C (ko)
AP (1) AP2001002207A0 (ko)
AT (1) ATE254126T1 (ko)
AU (1) AU760875B2 (ko)
BR (1) BR9916849A (ko)
CA (1) CA2355712C (ko)
CZ (1) CZ20012352A3 (ko)
DE (1) DE69912842T2 (ko)
DK (1) DK1140937T3 (ko)
EA (1) EA004767B1 (ko)
ES (1) ES2209532T3 (ko)
HU (1) HUP0104827A3 (ko)
ID (1) ID30477A (ko)
IL (1) IL143867A0 (ko)
MX (1) MXPA01006425A (ko)
NO (1) NO20013163L (ko)
NZ (1) NZ513094A (ko)
OA (1) OA11741A (ko)
PT (1) PT1140937E (ko)
TR (1) TR200102501T2 (ko)
UY (1) UY25878A1 (ko)
WO (1) WO2000039143A2 (ko)
ZA (1) ZA200105702B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1140937E (pt) * 1998-12-23 2004-04-30 Shire Biochem Inc Analogos de nucleosidos antivirais
WO2001058894A1 (en) * 2000-02-11 2001-08-16 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
AU2003261114A1 (en) * 2002-07-03 2004-02-09 Triangle Pharmaceuticals, Inc. Combination therapy with 1,3-dioxolanes and inosine monophosphate dehydrogenase inhibitors
ES2360096T3 (es) 2002-08-06 2011-05-31 Pharmasset, Inc. Procedimientos de preparación de nucleosidos de 1,3-dioxolano.
US7706405B2 (en) * 2002-09-12 2010-04-27 Interdigital Technology Corporation System for efficient recovery of Node-B buffered data following MAC layer reset
ES2318179T3 (es) * 2002-11-18 2009-05-01 Shire Canada Inc. Procedimiento estereoselectivo para la produccion de analogos de nucleosidos de dioxolano.
DE10335061B4 (de) * 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
CN105039489A (zh) 2004-02-03 2015-11-11 埃莫里大学 制备1,3-二氧戊环核苷的方法
US7322412B2 (en) * 2004-08-30 2008-01-29 Halliburton Energy Services, Inc. Casing shoes and methods of reverse-circulation cementing of casing
ES2369619T3 (es) * 2008-03-20 2011-12-02 Befesa Salzschlacke Gmbh Materia prima con alto contenido en arcilla de aluminio y método para su fabricación.
WO2012048455A1 (zh) * 2010-10-12 2012-04-19 武汉大学 一种抗病毒透皮吸收贴片及其制备方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041037A (en) 1975-06-10 1977-08-09 American Home Products Corporation Antitumor derivatives of periodate-oxidized cytidine
US4000137A (en) 1975-06-10 1976-12-28 American Home Products Corporation Antitumor derivatives of periodate-oxidized nucleosides
JPS5668674A (en) 1979-11-08 1981-06-09 Shionogi & Co Ltd 5-fluorouracil derivative
JPS5738774A (en) 1980-08-19 1982-03-03 Chugai Pharmaceut Co Ltd Uracil derivative and its preparation
US4479942A (en) 1981-08-10 1984-10-30 Fujisawa Pharmaceutical Co., Ltd. Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
HU198933B (en) 1987-11-02 1989-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5041449A (en) 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5270315A (en) 1988-04-11 1993-12-14 Biochem Pharma Inc. 4-(purinyl bases)-substituted-1,3-dioxlanes
US4987224A (en) 1988-08-02 1991-01-22 University Of Georgia Research Foundation, Inc. Method of preparation of 2',3'-dideoxynucleosides
PT674634E (pt) 1989-02-08 2003-09-30 Iaf Biochem Int Processos para preparar 1,3-oxatiolanos substituidos com propriedades antivirais
PT95516A (pt) * 1989-10-06 1991-08-14 Wellcome Found Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos
US5700937A (en) 1990-02-01 1997-12-23 Emory University Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US6642245B1 (en) 1990-02-01 2003-11-04 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
EP0560794B1 (en) 1990-11-13 1996-09-18 Biochem Pharma Inc Substituted 1,3-oxathiolanes with antiviral properties
US5444063A (en) 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
WO1992010496A1 (en) 1990-12-05 1992-06-25 University Of Georgia Research Foundation, Inc. ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
US5179104A (en) 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
US5925643A (en) 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
IL100965A (en) 1991-02-22 1999-12-31 Univ Emory 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9109506D0 (en) 1991-05-02 1991-06-26 Wellcome Found Therapeutic nucleosides
GB9110874D0 (en) 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9200150D0 (en) * 1992-01-06 1992-02-26 Wellcome Found Therapeutic nucleosides
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
GB9525606D0 (en) * 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
US5792773A (en) 1996-11-15 1998-08-11 Yale University L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection
PT1140937E (pt) * 1998-12-23 2004-04-30 Shire Biochem Inc Analogos de nucleosidos antivirais

Also Published As

Publication number Publication date
US6545001B2 (en) 2003-04-08
HUP0104827A2 (en) 2002-06-29
JP2002533470A (ja) 2002-10-08
KR100653485B1 (ko) 2006-12-04
CA2355712C (en) 2009-03-17
US20040058893A1 (en) 2004-03-25
DE69912842D1 (de) 2003-12-18
US20010049372A1 (en) 2001-12-06
AP2001002207A0 (en) 2001-09-30
EA200100711A1 (ru) 2001-12-24
UY25878A1 (es) 2001-08-27
ES2209532T3 (es) 2004-06-16
CZ20012352A3 (cs) 2001-10-17
WO2000039143A3 (en) 2000-11-02
AU760875B2 (en) 2003-05-22
KR20020013485A (ko) 2002-02-20
NZ513094A (en) 2004-05-28
ATE254126T1 (de) 2003-11-15
NO20013163D0 (no) 2001-06-22
BR9916849A (pt) 2001-10-30
CN1117751C (zh) 2003-08-13
PT1140937E (pt) 2004-04-30
IL143867A0 (en) 2002-04-21
HUP0104827A3 (en) 2002-08-28
EP1140937A2 (en) 2001-10-10
EA004767B1 (ru) 2004-08-26
WO2000039143A2 (en) 2000-07-06
NO20013163L (no) 2001-08-20
ID30477A (id) 2001-12-13
CN1334814A (zh) 2002-02-06
CA2355712A1 (en) 2000-07-06
EP1140937B1 (en) 2003-11-12
ZA200105702B (en) 2002-10-11
OA11741A (en) 2005-05-13
DK1140937T3 (da) 2004-03-22
DE69912842T2 (de) 2004-05-13
MXPA01006425A (es) 2002-06-04
US6358963B1 (en) 2002-03-19
AU1765700A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
NO961377L (no) Distamycin A-analoger som antitumor eller antivirale midler
DK1280813T3 (da) Antivirale pyrimidin-nukleosidanaloger
CY1116145T1 (el) S-φθορομεθυλεστερας 6.αλφα.,9.αλφα-διφθορο-17.αλφα.-'(2-φουρανυλκαρβοξυλ) οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4-διεν-17-καρβοθειοτικου οξεος ως αντιφλεγμονωδης παραγοντας
DZ3007A1 (fr) Analogues de (1 R, CIS)-4-(6-amino-9H-purin-9-YL)-2-cyclopentène-1-methanol comme agents antiviraux.
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
NO20035524D0 (no) 4'-substituerte nukleosider
HUP0001843A2 (hu) Eljárás nukleozid analógok szintézisére
MY122262A (en) Lh-rh peptide analogues their uses and pharmaceutical compositions containing them
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
PT1075259E (pt) Novos analogos gordos para o tratamento de diabetes
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
BG106567A (en) Purine derivatives
AP2001002361A0 (en) Purine derivatives.
EA199800752A1 (ru) Пентафторбензолсульфонамиды и их аналоги
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
TR200102501T2 (tr) Antiviral nükleozid analoglar.
ATE345349T1 (de) Purinderivate
MXPA02012493A (es) 1-aril-4-oxo, 1,4-dihidro-3-quinolincarboxamidas como agentes antivirales.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
DK1250337T3 (da) Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
SE9604582D0 (sv) Novel compounds
BR9901476A (pt) Polissulfetos de bis (éster hidroxialquil alquìlico).
BR9907426A (pt) Tetrahidronaftalenos